User:Atodheartrocks/sandbox: Difference between revisions – Wikipedia

For Psycho-oncology ([[Psycho-oncology]]) Depression and anxiety section:

A meta-analysis of 211 studies evaluating depression in patients with cancer concluded a general prevalence estimate ranging from approximately 8% to 24%, depending on the assessment method used, around 13% when diagnosed through structured clinical interviews and approximately 24% when measured by self-report. (<nowiki>https://pmc.ncbi.nlm.nih.gov/articles/PMC4282549/</nowiki>)  The analysis determined variation by cancer type and treatment phase, with higher rates being observed during active treatment (approximately 14% by interview and 27% by self-report) and lower rates after one year post-diagnosis. Prevalence rates ranged from approximately 3% in lung cancer to 31% in digestive tract cancers when assessed by interview. The study noted substantial heterogeneity among included studies and emphasized the influence of assessment method, cancer type, and stage of illness on reported prevalence rates.

Depression and anxiety in individuals with cancer have been shown to affect multiple psychosocial domains, including social functioning, treatment engagement, and overall wellbeing. Psychological distress can contribute to reduced adherence to medical treatment, impaired communication with healthcare providers and loved ones, and difficulties maintaining social relationships and professional roles. “(<nowiki>https://pubmed.ncbi.nlm.nih.gov/23759376/</nowiki>) Elevated psychological distress also has been associated with poorer coping skills, diminished social support, and lower perceived self-efficacy in managing illness-related challenges. (<nowiki>https://pubmed.ncbi.nlm.nih.gov/23759376/</nowiki>) Addressing these psychosocial factors through early screening and supportive interventions is recognized within psycho-oncology as a valuable component of comprehensive and holistic cancer care.{{dashboard.wikiedu.org sandbox}}